MoneyWorks4Me

Themis Medicare informs about outcome of board meeting

28 Jul 2022 Evaluate

Themis Medicare has informed that the Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30lh June, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..